Aberrant expression of the cell polarity regulator aPKCλ/i is associated with disease progression in cervical intraepithelial neoplasia (CIN): A possible marker for predicting CIN prognosis

International Journal of Gynecological Pathology

Volumn 35, Issue 2, 2016, Pages 106-117

  Mizushima, Taichi ^a,b   Asai Sato, Mikiko ^a   Akimoto, Kazunori ^b,d   Nagashima, Yoji ^c,e   Taguri, Masataka ^a   Sasaki, Kazunori ^b   Nakaya, Masa Aki ^b   Asano, Ryoko ^a   Tokinaga, Aya ^a   Kiyono, Tohru ^f   Hirahara, Fumiki ^a   Ohno, Shigeo ^b   Miyagi, Etsuko ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Molecular Biology   (Japan)

^c Molecular Pathology   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

^e TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

^f NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Atypical protein kinase C i (aPKC i); Biomarker; Cervical cancer; Cervical intraepithelial neoplasia (CIN); Subcellular localization.

Indexed keywords

ATYPICAL PROTEIN KINASE C LAMBDA IOTA; PROTEIN KINASE C IOTA; PROTEIN KINASE C LAMBDA; REGULATOR PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; PKC-3 PROTEIN; PROTEIN KINASE C;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CELL POLARITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRANSFECTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; TUMOR BIOPSY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; BIOSYNTHESIS; COMPLICATION; DISEASE COURSE; KAPLAN MEIER METHOD; METABOLISM; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; BIOMARKERS, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; PROTEIN KINASE C; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 84958902017     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0000000000000228     Document Type: Article

References (35)

1. Nash JD, Burke TW, Hoskins WJ. Biologic course of cervical human papillomavirus infection. Obstet Gynecol. 1987;69: 160-2.
2. Yokoyama M, Iwasaka T, Nagata C, et al. Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: A cohort study in Japan. Cancer Lett. 2003;192: 171-9.
3. Takeda T, Wong TF, Adachi T, et al. Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2011 edition. J Obstet Gynaecol Res. 2012;38: 615-31.
4. Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17:S1-27.
5. Martin CM, OLeary JJ. Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract Res Clin Obstet Gynaecol. 2011;25:605-15.
6. Akimoto K, Takahashi R, Moriya S, et al. EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase. EMBO J. 1996;15:788-98.
7. Ohno S. Intercellular junctions and cellular polarity: The PARaPKC complex, a conserved core cassette playing fundamental roles in cell polarity. Curr Opin Cell Biol. 2001;13:641-8.
8. Suzuki A, Akimoto K, Ohno S. Protein kinase C lambda/iota (PKClambda/iota): A PKC isotype essential for the development of multicellular organisms. J Biochem. 2003;133:9-16.
9. Regala RP, Weems C, Jamieson L, et al. Atypical protein kinase C iota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem. 2005;280:31109-15.
10. Eder AM, Sui X, Rosen DG, et al. Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci USA. 2005;102:12519-24.
11. Zhang L, Huang J, Yang N, et al. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res. 2006;66:4627-35.
12. Patel R, Win H, Desai S, et al. Involvement of PKC-iota in glioma proliferation. Cell Prolif. 2008;41:122-35.
13. Ishiguro H, Akimoto K, Nagashima Y, et al. aPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6. Proc Natl Acad Sci USA. 2009;106:16369-74.
14. Kojima Y, Akimoto K, Nagashima Y, et al. The overexpression and altered localization of the atypical protein kinase C lambda/iota in breast cancer correlates with the pathologic type of these tumors. Hum Pathol. 2008; 39:824-31.
15. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-84.
16. Bergeron C, Ordi J, Schmidt D, et al. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing highgrade cervical intraepithelial neoplasia. Am J Clin Pathol. 2010;133:395-406.
17. Nagano H, Yoshikawa H, Kawana T, et al. Association of multiple human papillomavirus types with vulvar neoplasias. J Obstet Gynaecol Res. 1996;22:1-8.
18. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-9.
19. Narisawa-Saito M, Yoshimatsu Y, Ohno S, et al. An in vitro multistep carcinogenesis model for human cervical cancer. Cancer Res. 2008;68:5699-705.
20. Liu X, Wang L, Shen Y, et al. Disruption of precise regulation of alphaPKC expression and cellular localization is associated with cervical cancer progression. Arch Gynecol Obstet. 2013;288:401-8.
21. Parker PJ, Justilien V, Riou P, et al. Atypical protein kinase C iota as a human oncogene and therapeutic target. Biochem Pharmacol. 2014;88:1-11.
22. Takagawa R, Akimoto K, Ichikawa Y, et al. High expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic factor for recurrence. Ann Surg Oncol. 2010;17:81-8.
23. Regala RP, Weems C, Jamieson L, et al. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res. 2005;65:8905-11.
24. Ishiguro H, Akimoto K, Nagashima Y, et al. Coexpression of aPKClambda/iota and IL-6 in prostate cancer tissue correlates with biochemical recurrence. Cancer Sci. 2011;102:1576-81.
25. Murray NR, Kalari KR, Fields AP. Protein kinase Ciota expression and oncogenic signaling mechanisms in cancer. J Cell Physiol. 2011;226:879-87.
26. Kato S, Akimoto K, Nagashima Y, et al. aPKClambda/iota is a beneficial prognostic marker for pancreatic neoplasms. Pancreatology. 2013;13:360-8.
27. Sabherwal N, Tsutsui A, Hodge S, et al. The apicobasal polarity kinase aPKC functions as a nuclear determinant and regulates cell proliferation and fate during Xenopus primary neurogenesis. Development. 2009;136:2767-77.
28. Matsumoto K, Oki A, Furuta R, et al. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study. Int J Cancer. 2011;128:2898-910.
29. Hosaka M, Fujita H, Hanley SJ, et al. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women. Int J Cancer. 2013;132:327-34.
30. Quint KD, de Koning MN, Quint WG, et al. Progression of cervical low grade squamous intraepithelial lesions: in search of prognostic biomarkers. Eur J Obstet Gynecol Reprod Biol. 2013;170:501-6.
31. Liao GD, Sellors JW, Sun HK, et al. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: A prospective study in China. Int J Cancer. 2014;134:1715-24.
32. Kruse AJ, Baak JP, Janssen EA, et al. Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model. Cell Oncol. 2004;26:13-20.
33. Guo M, Baruch AC, Silva EG, et al. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Am J Clin Pathol. 2011;135:212-20.
34. Ozaki S, Zen Y, Inoue M. Biomarker expression in cervical intraepithelial neoplasia: potential progression predictive factors for low-grade lesions. Hum Pathol. 2011;42: 1007-12.
35. Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin Number 131: screening for cervical cancer. Obstet Gynecol. 2012;120:1222-38.